全文获取类型
收费全文 | 12562篇 |
免费 | 919篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 296篇 |
妇产科学 | 375篇 |
基础医学 | 2108篇 |
口腔科学 | 184篇 |
临床医学 | 1186篇 |
内科学 | 3097篇 |
皮肤病学 | 189篇 |
神经病学 | 1169篇 |
特种医学 | 257篇 |
外科学 | 1270篇 |
综合类 | 67篇 |
一般理论 | 3篇 |
预防医学 | 1100篇 |
眼科学 | 182篇 |
药学 | 935篇 |
中国医学 | 32篇 |
肿瘤学 | 1020篇 |
出版年
2023年 | 135篇 |
2022年 | 310篇 |
2021年 | 505篇 |
2020年 | 267篇 |
2019年 | 358篇 |
2018年 | 423篇 |
2017年 | 312篇 |
2016年 | 308篇 |
2015年 | 415篇 |
2014年 | 477篇 |
2013年 | 658篇 |
2012年 | 969篇 |
2011年 | 906篇 |
2010年 | 524篇 |
2009年 | 455篇 |
2008年 | 763篇 |
2007年 | 812篇 |
2006年 | 729篇 |
2005年 | 667篇 |
2004年 | 565篇 |
2003年 | 580篇 |
2002年 | 513篇 |
2001年 | 136篇 |
2000年 | 150篇 |
1999年 | 153篇 |
1998年 | 108篇 |
1997年 | 85篇 |
1996年 | 65篇 |
1995年 | 42篇 |
1994年 | 36篇 |
1993年 | 46篇 |
1992年 | 81篇 |
1991年 | 83篇 |
1990年 | 70篇 |
1989年 | 70篇 |
1988年 | 51篇 |
1987年 | 66篇 |
1986年 | 59篇 |
1985年 | 56篇 |
1984年 | 34篇 |
1983年 | 23篇 |
1981年 | 31篇 |
1979年 | 29篇 |
1978年 | 37篇 |
1977年 | 31篇 |
1975年 | 24篇 |
1974年 | 26篇 |
1973年 | 26篇 |
1971年 | 30篇 |
1969年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China 总被引:2,自引:0,他引:2
Background China is one of the high burden countries of Mycobacterium tuberculosis (TB) infection globally, with high incidence and mortality. We studied the molecular characteristics of rifampin (RIF) and isoniazid (INH) resistant Mycobacterium tuberculosis strains from Beijing, China, in order to find out the genetic marker for rapid detection of specific drug resistance.
Methods Forty pansusceptible and 81 resistant strains of Mycobacterium tuberculosis isolated from Beijing, China during 2002-2005 were analyzed. The modified rifampin oligonucleotide (RIFO) assay based on reverse line blot hybridization was used to detect mutations in the 81 bp hot-spot region of rpoB gene, which is associated with RIF resistance. The INH resistance associated genes, regulatory region mab-inhA (-15C/T) and structural gene katG S315T were detected by reverse line blot hybridization and PCR-restriction fragment length polymorphism (RFLP) method respectively. All the strains were typed by spoligotying and the Beijing genotype was further subdivided by NTF locus analysis. The distribution of drug resistance associated mutations in the above genes was compared in these groups.
Results Sixty-five (91.5%) of 71 RIF resistant and 52 (92.9%) of 56 multidrug-resistant (MDR, i.e. resistant to at least RIF and INH) strains were found to harbor mutations in the rpoB hot-spot region. No mutation was detected in RIF sensitive strains. The specificity and sensitivity of the modified RIFO assay were 100% and 91.5%, respectively, katG315 AGC〉ACC and inhA-15C〉T mutations were found in 40 (60.6%) and 10 (15.2%) of 66 INH resistant strains, respectively; 7.6% of INH-resistant strains had mutations in both of these genes. Therefore, a combined use of both katG315 and inhA-15 identified 68.2% of INH-resistant strains. The Beijing genotype accounted for 91.7% of total strains and was further subdivided into "modern" (76.6%) and "ancestral" (23.4%) group. There is no significant difference between "ancestral" and "modern" group in prevalance of drug resistance-associated gene mutations.
Conclusions The hot-spot region of rpoB gene can be used as genetic marker for detection of RIF resistant strains; a combined use of both katG315 and inhA-15 can improve the detection rate of I NH resistant strains; the Beijing genotype is prevalent in Beijing, China; the modified RIFO assay can be a practical tool for rapid detection of RIF resistant and MDR isolates in the routine diagnostic work. 相似文献
102.
Nerea Becerra-Tomás Andrés Díaz-López Núria Rosique-Esteban Emilio Ros Pilar Buil-Cosiales Dolores Corella Ramon Estruch Montserrat Fitó Lluís Serra-Majem Fernando Arós Rosa Maria Lamuela-Raventós Miquel Fiol José Manuel Santos-Lozano Javier Díez-Espino Olga Portoles Jordi Salas-Salvadó 《Clinical nutrition (Edinburgh, Scotland)》2018,37(3):906-913
103.
104.
Tatiana Safronova Andrey Kiselev Irina Selezneva Tatiana Shatalova Yulia Lukina Yaroslav Filippov Otabek Toshev Snezhana Tikhonova Olga Antonova Alexander Knotko 《Materials》2022,15(9)
Ceramic samples based on β-calcium pyrophosphate β-Ca2P2O7 were prepared from powders of γ-calcium pyrophosphate γ-Ca2P2O7 with preset molar ratios Ca/P = 1, 0.975 and 0.95 using firing at 900, 1000, and 1100 °C. Calcium lactate pentahydrate Ca(C3H5O3)2⋅5H2O and monocalcium phosphate monohydrate Ca(H2PO4)2⋅H2O were treated in an aqua medium in mechanical activation conditions to prepare powder mixtures with preset molar ratios Ca/P containing calcium hydrophosphates with Ca/P = 1 (precursors of calcium pyrophosphate Ca2P2O7). These powder mixtures containing calcium hydrophosphates with Ca/P = 1 and non-reacted starting salts were heat-treated at 600 °C after drying and disaggregation in acetone. Phase composition of all powder mixtures after heat treatment at 600 °C was presented by γ-calcium pyrophosphate γ-Ca2P2O7 according to the XRD data. The addition of more excess of monocalcium phosphate monohydrate Ca(H2PO4)2·H2O (with appropriate molar ratio of Ca/P = 1) to the mixture of starting components resulted in lower dimensions of γ-calcium pyrophosphate (γ-Ca2P2O7) individual particles. The grain size of ceramics increased both with the growth in firing temperature and with decreasing molar ratio Ca/P of powder mixtures. Calcium polyphosphate (t melt = 984 °C), formed from monocalcium phosphate monohydrate Ca(H2PO4)2⋅H2O, acted similar to a liquid phase sintering additive. It was confirmed by tests in vitro that prepared ceramic materials with preset molar ratios Ca/P = 1, 0.975, and 0.95 and phase composition presented by β-calcium pyrophosphate β-Ca2P2O7 were biocompatible and could maintain bone cells proliferation. 相似文献
105.
106.
Anton R. Kiselev M.D. D.Sc. Vladimir I. Gridnev M.D. D.Sc. Mikhail D. Prokhorov D.Sc. Anatoly S. Karavaev Ph.D. Olga M. Posnenkova M.D. Ph.D. Vladimir I. Ponomarenko D.Sc. Boris P. Bezruchko D.Sc. Vladimir A. Shvartz M.D. Ph.D. 《Annals of noninvasive electrocardiology》2012,17(3):204-213
Background: Synchronization between 0.1‐Hz rhythms in cardiovascular system is deteriorated at acute myocardial infarction (AMI) leading to a disruption of natural functional couplings within the system of autonomic regulation. Objective: This study evaluates the prognostic value of autonomic regulation indices for the 5‐year risk of fatal and nonfatal cardiovascular events in patients after AMI. Methods and Results: We studied 125 patients (53 [42%] female) after AMI aged between 30 and 83 years. The period of observation was 5 years with checkpoints at the first week after AMI and after each year after AMI. We compared the prognostic value of established clinical characteristics and degree S of synchronization between 0.1‐Hz rhythms in heart rate and microcirculation for evaluation of the 5‐year risk of mortality and recurrent myocardial infarction (MI) in patients after AMI. Acute heart failure Killip 2–4 at AMI and S < 20% at the first week after AMI were identified as the most important factors for evaluation of the risk of 5‐year mortality in patients after AMI (χ2= 14.2, P = 0.003). Sensitivity and specificity of low S (<20%) at the first week after AMI were 76% and 43%, respectively. For evaluation of the 5‐year risk of recurrent MI index S had no advantage over established clinical characteristics. Conclusion: The value of S below 20% in patients with AMI is a sensitive marker of high risk of mortality during the subsequent five years. It is characterized by better prognostic value than most of established clinical characteristics. 相似文献
107.
108.
Kurt Seetoo Maria Paz Carlos David Blythe Leena Trivedi Robert Myers Tracey England Criscelia Agee Bill Arnold Carolyn Dobbs Mary McIntyre Enrique Ramirez Julie Morita Saadeh Ewaidah Wilete Ishow Teresa Chou Kenneth Soyemi Albert E. Barskey Amy Parker Fiebelkorn Paul Lucas Emily S. Abernathy Joseph P. Icenogle Gregory S. Wallace Susan E. Reef Yoran Grant 《MMWR. Morbidity and mortality weekly report》2013,62(12):226-229
109.
110.